 | • レポートコード：GIR-105X08096 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、インフルエンザ菌B型ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。インフルエンザ菌B型ワクチンの種類別市場規模（液体一価HIB、液体コンビネーションHIB、凍結乾燥一価HIB、凍結乾燥コンビネーションHIB）、用途別市場規模（病院、研究機関、製薬・バイオ技術企業、学術機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・インフルエンザ菌B型ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Merck、Sanofi、GlaxoSmithKline、Takeda Pharmaceuticals Company、Walvax Biotechnology、Lanzhou Institute of Biologica、Immunize BC ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：液体一価HIB、液体コンビネーションHIB、凍結乾燥一価HIB、凍結乾燥コンビネーションHIB ・用途別分析2016年-2026年：病院、研究機関、製薬・バイオ技術企業、学術機関、その他 ・インフルエンザ菌B型ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・インフルエンザ菌B型ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・インフルエンザ菌B型ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・インフルエンザ菌B型ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・インフルエンザ菌B型ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Haemophilus Influenzae Type B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Haemophilus Influenzae Type B Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Haemophilus Influenzae Type B Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Haemophilus Influenzae Type B Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liquid Monovalent HIB
Liquid Combination HIB
Lyophilized Monovalent HIB
Lyophilized Combination HIB
Market segment by Application can be divided into
Hospital
Research Institutions
Pharmaceutical and Biotechnology Companies
Academic Institutions
Other
The key market players for global Haemophilus Influenzae Type B Vaccine market are listed below:
Novartis
Merck
Sanofi
GlaxoSmithKline
Takeda Pharmaceuticals Company
Walvax Biotechnology
Lanzhou Institute of Biologica
Immunize BC
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Haemophilus Influenzae Type B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Haemophilus Influenzae Type B Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Liquid Monovalent HIB
1.2.3 Liquid Combination HIB
1.2.4 Lyophilized Monovalent HIB
1.2.5 Lyophilized Combination HIB
1.3 Market Analysis by Application
1.3.1 Overview: Global Haemophilus Influenzae Type B Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Global Haemophilus Influenzae Type B Vaccine Market Size & Forecast
1.4.1 Global Haemophilus Influenzae Type B Vaccine Sales in Value (2016-2026))
1.4.2 Global Haemophilus Influenzae Type B Vaccine Sales in Volume (2016-2026)
1.4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Haemophilus Influenzae Type B Vaccine Production Capacity Analysis
1.5.1 Global Haemophilus Influenzae Type B Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Haemophilus Influenzae Type B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Haemophilus Influenzae Type B Vaccine Market Drivers
1.6.2 Haemophilus Influenzae Type B Vaccine Market Restraints
1.6.3 Haemophilus Influenzae Type B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Haemophilus Influenzae Type B Vaccine Product and Services
2.1.4 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Haemophilus Influenzae Type B Vaccine Product and Services
2.2.4 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Product and Services
2.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product and Services
2.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Takeda Pharmaceuticals Company
2.5.1 Takeda Pharmaceuticals Company Details
2.5.2 Takeda Pharmaceuticals Company Major Business
2.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product and Services
2.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product and Services
2.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Lanzhou Institute of Biologica
2.7.1 Lanzhou Institute of Biologica Details
2.7.2 Lanzhou Institute of Biologica Major Business
2.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product and Services
2.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Immunize BC
2.8.1 Immunize BC Details
2.8.2 Immunize BC Major Business
2.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Product and Services
2.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Haemophilus Influenzae Type B Vaccine Sales by Manufacturer
3.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Haemophilus Influenzae Type B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Haemophilus Influenzae Type B Vaccine Manufacturer Market Share
3.4.2 Top 6 Haemophilus Influenzae Type B Vaccine Manufacturer Market Share
3.5 Global Haemophilus Influenzae Type B Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Haemophilus Influenzae Type B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Region
4.1.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2026)
4.2 North America Haemophilus Influenzae Type B Vaccine Revenue (2016-2026)
4.3 Europe Haemophilus Influenzae Type B Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue (2016-2026)
4.5 South America Haemophilus Influenzae Type B Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2026)
5.3 Global Haemophilus Influenzae Type B Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Haemophilus Influenzae Type B Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2026)
6.3 Global Haemophilus Influenzae Type B Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2026)
7.2 North America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2026)
7.3 North America Haemophilus Influenzae Type B Vaccine Market Size by Country
7.3.1 North America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2026)
8.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2026)
8.3 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country
8.3.1 Europe Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Haemophilus Influenzae Type B Vaccine Market Size by Region
9.3.1 Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2026)
10.2 South America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2026)
10.3 South America Haemophilus Influenzae Type B Vaccine Market Size by Country
10.3.1 South America Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Haemophilus Influenzae Type B Vaccine Market Size by Country
11.3.1 Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Haemophilus Influenzae Type B Vaccine Typical Distributors
12.3 Haemophilus Influenzae Type B Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Haemophilus Influenzae Type B Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Haemophilus Influenzae Type B Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Haemophilus Influenzae Type B Vaccine Product and Services
Table 6. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Haemophilus Influenzae Type B Vaccine Product and Services
Table 10. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Haemophilus Influenzae Type B Vaccine Product and Services
Table 14. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product and Services
Table 18. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Takeda Pharmaceuticals Company Basic Information, Manufacturing Base and Competitors
Table 20. Takeda Pharmaceuticals Company Major Business
Table 21. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product and Services
Table 22. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 24. Walvax Biotechnology Major Business
Table 25. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product and Services
Table 26. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Lanzhou Institute of Biologica Basic Information, Manufacturing Base and Competitors
Table 28. Lanzhou Institute of Biologica Major Business
Table 29. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product and Services
Table 30. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Immunize BC Basic Information, Manufacturing Base and Competitors
Table 32. Immunize BC Major Business
Table 33. Immunize BC Haemophilus Influenzae Type B Vaccine Product and Services
Table 34. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
Table 36. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Haemophilus Influenzae Type B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Haemophilus Influenzae Type B Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 39. Head Office and Haemophilus Influenzae Type B Vaccine Production Site of Key Manufacturer
Table 40. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 41. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026) & (M Doses)
Table 42. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 45. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (M Doses)
Table 46. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Haemophilus Influenzae Type B Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 49. Global Haemophilus Influenzae Type B Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 50. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 51. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (M Doses)
Table 52. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Haemophilus Influenzae Type B Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 55. Global Haemophilus Influenzae Type B Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 56. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 57. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (M Doses)
Table 58. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 61. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (M Doses)
Table 62. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 63. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (M Doses)
Table 64. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 65. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (M Doses)
Table 66. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 69. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (M Doses)
Table 70. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 71. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (M Doses)
Table 72. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 73. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026) & (M Doses)
Table 74. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 77. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (M Doses)
Table 78. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 79. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (M Doses)
Table 80. South America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 81. South America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (M Doses)
Table 82. South America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Haemophilus Influenzae Type B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 85. South America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (M Doses)
Table 86. South America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 87. South America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (M Doses)
Table 88. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 89. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (M Doses)
Table 90. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 93. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (M Doses)
Table 94. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 95. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (M Doses)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Haemophilus Influenzae Type B Vaccine Typical Distributors
Table 99. Haemophilus Influenzae Type B Vaccine Typical Customers
List of Figures
Figure 1. Haemophilus Influenzae Type B Vaccine Picture
Figure 2. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type in 2020
Figure 3. Liquid Monovalent HIB
Figure 4. Liquid Combination HIB
Figure 5. Lyophilized Monovalent HIB
Figure 6. Lyophilized Combination HIB
Figure 7. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Research Institutions
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Academic Institutions
Figure 12. Other
Figure 13. Global Haemophilus Influenzae Type B Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 14. Global Haemophilus Influenzae Type B Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Haemophilus Influenzae Type B Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Haemophilus Influenzae Type B Vaccine Sales (2016-2026) & (M Doses)
Figure 35. Global Haemophilus Influenzae Type B Vaccine Production Capacity (2016-2026) & (M Doses)
Figure 36. Global Haemophilus Influenzae Type B Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Haemophilus Influenzae Type B Vaccine Market Drivers
Figure 38. Haemophilus Influenzae Type B Vaccine Market Restraints
Figure 39. Haemophilus Influenzae Type B Vaccine Market Trends
Figure 40. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturer in 2020
Figure 41. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturer in 2020
Figure 42. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Haemophilus Influenzae Type B Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Haemophilus Influenzae Type B Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2026)
Figure 46. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2016-2026)
Figure 47. North America Haemophilus Influenzae Type B Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Europe Haemophilus Influenzae Type B Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue (2016-2026) & (USD Million)
Figure 50. South America Haemophilus Influenzae Type B Vaccine Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue (2016-2026) & (USD Million)
Figure 52. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2026)
Figure 53. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2026)
Figure 54. Global Haemophilus Influenzae Type B Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 55. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2026)
Figure 56. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2026)
Figure 57. Global Haemophilus Influenzae Type B Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 58. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2026)
Figure 59. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2026)
Figure 60. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2026)
Figure 61. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2026)
Figure 62. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2026)
Figure 63. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2026)
Figure 64. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2026)
Figure 65. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2026)
Figure 70. South America Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2026)
Figure 71. South America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2026)
Figure 72. South America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2026)
Figure 73. South America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の水痘（水疱瘡）ワクチン市場 2021：企業別、地域別、種類・用途別 The Chickenpox (Varicella) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- ヒトのワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administ…
- 結合体ワクチンの世界市場2018-2025 Conjugate vaccines are formed by covalently bonding a weak antigen to the strong antigen. It boosts the hosts’ immune response. Conjugate vaccines are germ specific and can identify targeted germ only, so it can be used as a preventative measure to provide additional protection. Conjugate vaccines a…
- 破傷風トキソイドワクチンの世界市場2018-2025 Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms.US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. In 2018, the global Tetanus Toxoid Vaccine market size was xx million US$ and is forecast to …
- 世界の4価インフルエンザワクチン市場 2021：企業別、地域別、種類・用途別 The Quadrivalent Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…